Johan Lars Isaksson

Comparative study of lung cancer care and survival outcomes across the Nordic countries

Khalife, Ghida; Waris, Juho; Bødtger, Uffe; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 734-741, 2025

• DOI för Comparative study of lung cancer care and survival outcomes across the Nordic countries
• Ladda ner fulltext (pdf) av Comparative study of lung cancer care and survival outcomes across the Nordic countries

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Ingår i Translational Lung Cancer Research, s. 1972-1985, 2025

• DOI för Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Ladda ner fulltext (pdf) av Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Lindberg, Amanda; Muhl, Lars; Yu, Hui; Hellberg, Louise et al.

Ingår i Journal of Thoracic Oncology, s. 625-640, 2025

• DOI för In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC
• Ladda ner fulltext (pdf) av In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival

Eklund, Ella A.; Orgard, Mathilda; Wallin, Delice; Sayin, Sama I. et al.

Ingår i Lung Cancer, 2025

• DOI för Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
• Ladda ner fulltext (pdf) av Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival

Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

Neumann, Kirill; Berg, Janna; Ashraf, Haseem; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 22-26, 2025

• DOI för Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey
• Ladda ner fulltext (pdf) av Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

Comparative study of lung cancer care and survival outcomes across the Nordic countries

Khalife, Ghida; Waris, Juho; Bødtger, Uffe; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 734-741, 2025

• DOI för Comparative study of lung cancer care and survival outcomes across the Nordic countries
• Ladda ner fulltext (pdf) av Comparative study of lung cancer care and survival outcomes across the Nordic countries

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Ingår i Translational Lung Cancer Research, s. 1972-1985, 2025

• DOI för Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Ladda ner fulltext (pdf) av Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Lindberg, Amanda; Muhl, Lars; Yu, Hui; Hellberg, Louise et al.

Ingår i Journal of Thoracic Oncology, s. 625-640, 2025

• DOI för In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC
• Ladda ner fulltext (pdf) av In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC

Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival

Eklund, Ella A.; Orgard, Mathilda; Wallin, Delice; Sayin, Sama I. et al.

Ingår i Lung Cancer, 2025

• DOI för Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
• Ladda ner fulltext (pdf) av Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival

Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

Neumann, Kirill; Berg, Janna; Ashraf, Haseem; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 22-26, 2025

• DOI för Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey
• Ladda ner fulltext (pdf) av Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer

Backman, Max; Strell, Carina; Lindberg, Amanda; Mattsson, Johanna S. M. et al.

Ingår i European Journal of Cancer, s. 40-52, 2023

• DOI för Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
• Ladda ner fulltext (pdf) av Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer

KRAS G12C mutant non-small cell lung cancer linked to female sex and high risk of CNS metastasis: Population-based demographics and survival data from the National Swedish Lung Cancer Registry

Isaksson, Johan; Berglund, Anders; Louie, Karly; Willén, Linda et al.

Ingår i Clinical Lung Cancer, s. 507-518, 2023

• DOI för KRAS G12C mutant non-small cell lung cancer linked to female sex and high risk of CNS metastasis: Population-based demographics and survival data from the National Swedish Lung Cancer Registry
• Ladda ner fulltext (pdf) av KRAS G12C mutant non-small cell lung cancer linked to female sex and high risk of CNS metastasis: Population-based demographics and survival data from the National Swedish Lung Cancer Registry

Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer

Isaksson, Johan; Wennström, Leo; Brandén, Eva; Koyi, Hirsh et al.

Ingår i Cancer Treatment and Research Communications, 2022

• DOI för Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer
• Ladda ner fulltext (pdf) av Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer

Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden)

Willén, Linda; Berglund, Anders; Bergström, Stefan; Isaksson, Johan et al.

Ingår i PLOS ONE, 2022

• DOI för Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden)
• Ladda ner fulltext (pdf) av Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden)

Are older patients with non-small cell lung cancer receiving optimal care?: A population-based study

Willen, Linda; Berglund, Anders; Bergström, Stefan; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 309-317, 2022

• DOI för Are older patients with non-small cell lung cancer receiving optimal care?: A population-based study
• Ladda ner fulltext (pdf) av Are older patients with non-small cell lung cancer receiving optimal care?: A population-based study

Reply to Assoc. Prof. Kocak: ARTICLE COMMENTARIES: CLINICAL ONCOLOGY

Willén, Linda; Berglund, Anders; Bergström, Stefan; Isaksson, Johan et al.

Ingår i Acta Oncologica, s. 320-320, 2022

• DOI för Reply to Assoc. Prof. Kocak: ARTICLE COMMENTARIES: CLINICAL ONCOLOGY

Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer

Qvick, Alvida; Stenmark, Bianca; Carlsson, Jessica; Isaksson, Johan et al.

Ingår i Molecular Medicine, 2021

• DOI för Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
• Ladda ner fulltext (pdf) av Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer

Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade

Eltahir, Mohamed; Isaksson, Johan; Mattsson, Johanna Sofia Margareta; Karre, Klas et al.

Ingår i Cancers, 2021

• DOI för Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade
• Ladda ner fulltext (pdf) av Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade

Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer

Backman, Max; La Fleur, Linnea; Kurppa, Pinja; Djureinovic, Dijana et al.

Ingår i Journal of Pathology, s. 243-256, 2021

• DOI för Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
• Ladda ner fulltext (pdf) av Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11

La Fleur, Linnea; Falk-Sörqvist, Elin; Smeds, Patrik; Berglund, Anders et al.

Ingår i Lung Cancer, s. 50-58, 2019

• DOI för Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
• Ladda ner fulltext (pdf) av Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer

La Fleur, Linnea; Boura, Vanessa F.; Alexeyenko, Andrey; Berglund, Anders et al.

Ingår i International Journal of Cancer, s. 1741-1752, 2018

• DOI för Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer

The Molecular Epidemiology of Non-Small Cell Lung Cancer

Isaksson, Johan

2023

• Ladda ner fulltext (pdf) av The Molecular Epidemiology of Non-Small Cell Lung Cancer

Extending the immune phenotypes of lung cancer: Oasis in the desert

Backman, Max; La Fleur, Linnea; Kurppa, Pinja; Djureinovic, Dijana et al.

Plasma proteomic analysis in non-small cell lung cancer patients treated with PD1/PD-L1 blockade

Eltahir, Mohamed; Isaksson, Johan; Mattsson, Johanna Sofia Margareta; Kärre, Klas et al.